Angle plc Announces Business Update

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to provide a review of business progress, an unaudited trading update for 2022 and prospects for 2023.2022: a breakthrough yearGUILDFORD, SURREY / ACCESSWIRE / January 5, 2023 / 2022 has been a breakthrough year for ANGLE with the world’s first FDA product clearance for a system to harvest cancer cells from patient blood for subsequent analysis following a sustained effort by the Company for over six years including extensive dialogue and formal pre-submissions with FDA…
Read More